Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Sino Biopharmaceutical ( (HK:1177) ) is now available.
Sino Biopharmaceutical Limited announced the details of its upcoming annual general meeting scheduled for June 10, 2025. Key agenda items include the adoption of financial statements for 2024, approval of a final dividend, re-election of several directors, and the re-appointment of Ernst & Young as auditors. The meeting will also consider resolutions to authorize the board to issue additional shares, potentially impacting the company’s capital structure and shareholder value.
More about Sino Biopharmaceutical
Sino Biopharmaceutical Limited is a company incorporated in the Cayman Islands, operating within the pharmaceutical industry. The company is primarily focused on the development, manufacturing, and distribution of biopharmaceutical products.
YTD Price Performance: 26.92%
Average Trading Volume: 2,117
Technical Sentiment Signal: Sell
Current Market Cap: $9.25B
Learn more about 1177 stock on TipRanks’ Stock Analysis page.